APA (7th ed.) Citation

Yang, H., Zhu, A., Niu, Y., Ma, W., Xu, K., Jia, Y., . . . Yao, F. (2025). Distinct molecular subtypes of KRASG12C‐mutant lung adenocarcinoma: Insights into clinical outcomes, tumour microenvironments and therapeutic strategies. Clinical & Translational Medicine, 15(10), 1. https://doi.org/10.1002/ctm2.70490

Chicago Style (17th ed.) Citation

Yang, Haitang, et al. "Distinct Molecular Subtypes of KRASG12C‐mutant Lung Adenocarcinoma: Insights into Clinical Outcomes, Tumour Microenvironments and Therapeutic Strategies." Clinical & Translational Medicine 15, no. 10 (2025): 1. https://doi.org/10.1002/ctm2.70490.

MLA (9th ed.) Citation

Yang, Haitang, et al. "Distinct Molecular Subtypes of KRASG12C‐mutant Lung Adenocarcinoma: Insights into Clinical Outcomes, Tumour Microenvironments and Therapeutic Strategies." Clinical & Translational Medicine, vol. 15, no. 10, 2025, p. 1, https://doi.org/10.1002/ctm2.70490.